Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

NCT07654855 · clinicaltrials.gov ↗

RECRUITING

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloidosis
Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Polyneuropathy

Interventions

OTHER: None ( observational study )

Sponsor

AstraZeneca

Collaborators

[object Object]